Skip to content

In the BioHarmony Drug Report Database

Epoetin alfa

Epogen/Procrit, Procrit (epoetin alfa) is a protein pharmaceutical. Epoetin alfa was first approved as Epogen/Procrit on 1989-06-01. It is used to treat anemia in the USA. It has been approved in Europe to treat anemia, chronic kidney failure, and neoplasms. It is known to target erythropoietin receptor.
Trade Name Epogen/Procrit, Procrit
Common Name Epoetin alfa
Indication anemia, chronic kidney failure, neoplasms
Drug Class Erythropoietins
Epoetin alfa
Get full access now